Chi‐Yuan Chen

Chang Gung University of Science and Technology — Taiwan

Biochemistry, Genetics and Molecular Biology · Life Sciences

34h-index2.8kcitations131works10.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(25), Lung Cancer Treatments and Mutations(17), Cancer, Hypoxia, and Metabolism(12), Viral Infectious Diseases and Gene Expression in Insects(12), Virus-based gene therapy research(10)

Publications131 total

Abstract B066: Repurposed Therapeutic Targets DNA Repair and EGFR Signaling in EGFR-Mutant Lung Cancer
Molecular Cancer Therapeutics·2025
Enhancement of respiratory virus infection by air pollutants
Ecotoxicology and Environmental Safety·2025· 3 citedOpen Access
A Novel Strategy for Difficulty Estimation in the Guitar Fingering Problem
Lecture notes in electrical engineering·2025
The role of PM2.5 exposure in lung cancer: mechanisms, genetic factors, and clinical implications
EMBO Molecular Medicine·2024· 48 citedOpen Access
Abstract C029: PM2.5-induced drug resistance in lung cancer
Cancer Research·2024
Fine particulate matter manipulates immune response to exacerbate microbial pathogenesis in the respiratory tract
European Respiratory Review·2024· 21 citedOpen Access
OTUB1 contributes to the stability and function of Influenza A virus NS2
PLoS Pathogens·2024· 4 citedOpen Access
Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19
Journal of Nanobiotechnology·2024· 10 citedOpen Access
Corylin Attenuates CCl4-Induced Liver Fibrosis in Mice by Regulating the GAS6/AXL Signaling Pathway in Hepatic Stellate Cells
International Journal of Molecular Sciences·2023· 5 citedOpen Access
Supplementary Figure 2 from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
2023Open Access
Supplementary Table 2 from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
2023Open Access
Data from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
2023Open Access
Supplementary Methods from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
2023Open Access
Supplementary Figure 2 from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
2023Open Access
Data from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
2023Open Access
Supplementary Figure 3 from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
2023Open Access
Supplementary Table 1 from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
2023Open Access
Supplementary Figure 4 from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
2023Open Access
Supplementary Figure 4 from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
2023Open Access
Supplementary Table 1 from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Tong‐Hong Wang(17), Chih‐Cheng Chen(11), Pan‐Chyr Yang(10), Yu‐Chen Hu(9), Chuen Hsueh(8), Kuo‐Yen Huang(7), Shuenn-Chen Yang(5), Guan‐Yu Chen(4), Tse‐Ming Hong(4), Chau‐Ting Yeh(4), Yann-Lii Leu(4), Jeng‐Fan Lo(4), Chih‐Ching Wu(4), Yih‐Leong Chang(3), Hsuan‐Yu Chen(3), Wen‐Hsin Lo(3), Ya‐Hsuan Chang(3), Shu‐Huei Wang(3), Yann‐Lii Leu(3), Jang-Hau Lian(3)